MedPath

The effectiveness and safety evaluation of hair growth promotor containing teak leaf extract

Not Applicable
Completed
Conditions
Hair growth promotor in men who suffer from androgenic alopecia
Skin and Connective Tissue Diseases
Registration Number
ISRCTN24541842
Lead Sponsor
ational Research Council of Thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
90
Inclusion Criteria

Men who suffered from androgenic alopecia defined by Hamilton-Norwood type II to V, age 20-60 years old.

Exclusion Criteria

1. A lesion on the scalp
2. Sensitivity to hair growth promotors or minoxidil
3. Use of other hair-regrowth products for 3 months and/or minoxidil for 6 months before enrolling in this project
4. Systemic steroids for more than 14 days within 2 months before baseline evaluation
5. Medical history of radiation on the scalp
6. Personal chronic decreases i.e. chronic kidney disease, and non-controlled blood pressure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Target area hair count (TAHC), hair density, anagen hair count, and telogen hair count were measured by macro-photography trichoscopy Leviacam at baseline and every 4 weeks for a total duration of 24 weeks <br>2. Hair shedding measured using a combing test macro-photography trichoscopy Levicam at baseline and every 4 weeks for a total duration of 24 weeks <br>3. Safety and adverse effects measured by a dermatologist evaluation at baseline and every 4 weeks for a total duration of 24 weeks <br>4. Hair growth satisfaction measured using a questionnaire at the end of the study (week 24)
Secondary Outcome Measures
NameTimeMethod
There were no secondary outcome measures
© Copyright 2025. All Rights Reserved by MedPath